IRadimed Corporation (IRMD)
NASDAQ: IRMD · IEX Real-Time Price · USD
43.85
0.00 (0.00%)
At close: May 3, 2024, 4:00 PM
44.70
+0.85 (1.94%)
After-hours: May 3, 2024, 4:57 PM EDT

IRadimed Revenue

IRadimed had revenue of $67.69M in the twelve months ending March 31, 2024, with 19.87% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $17.60M with 13.72% year-over-year growth. In the year 2023, IRadimed had annual revenue of $65.56M with 23.00% growth.

Revenue (ttm)
$67.69M
Revenue Growth
+19.87%
P/S Ratio
8.36
Revenue / Employee
$457,333
Employees
148
Market Cap
566.09M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202365.56M12.26M23.00%
Dec 31, 202253.30M11.49M27.48%
Dec 31, 202141.81M10.10M31.83%
Dec 31, 202031.72M-6.80M-17.65%
Dec 31, 201938.52M8.08M26.54%
Dec 31, 201830.44M7.36M31.88%
Dec 31, 201723.08M-9.41M-28.97%
Dec 31, 201632.50M902.83K2.86%
Dec 31, 201531.59M15.94M101.84%
Dec 31, 201415.65M4.31M38.03%
Dec 31, 201311.34M3.66M47.56%
Dec 31, 20127.69M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
InnovAge Holding 720.80M
Accolade 414.29M
OmniAb 34.16M
Jin Medical International 19.82M
Nano-X Imaging 9.91M
Absci 5.72M
IGM Biosciences 2.13M
Revenue Rankings